Open access
Jul 2026
Cortistatin as a modulator of inflammatory and mitochondrial dysfunction in Huntington´s disease.
These results support cortistatin-based strategies as a promising disease-modifying therapeutic avenue for HD and related neurodegenerative disorders characterized by inflammatory activation and mitochondrial impairment.
P. González-García, I. Serrano-Martínez, Eliana Barriocanal-Casado et al.
· Journal of Neuroinflammation · 0 citations